BDBM306663 (1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(3,3- difluoroazetidin-1-yl)-15- oxatetracyclo- [6.6.1.02,7.09,14]pentadeca- 2,4,6,9,11,13-hexaene-4- carboxamide::US10144746, Compound 307
SMILES: NC(=N)c1ccc(CNC(=O)c2ccc3[C@H]4O[C@H](c5cc(ccc45)N4CC(F)(F)C4)c3c2)cc1
InChI Key: InChIKey=XQVFEDUMLXBJFY-PKTZIBPZSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasma kallikrein (Homo sapiens (Human)) | BDBM306663 ((1S,8R)-N-[(4-carbamimidoyl- phenyl)methyl]-12-(3,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Global Blood Therapeutics, Inc. US Patent | Assay Description The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w... | US Patent US10144746 (2018) BindingDB Entry DOI: 10.7270/Q2J38VNH | |||||||||||
More data for this Ligand-Target Pair |